Surface expression of CD19 and CD34 was not significantly different between EP300-ZNF384 (n = 7) and other pre-B-ALL groups (p = 0.7882 and p = 0.1916, respectively) (Fig. 1b). The gene discussed is CD34; the disease is acute lymphoblastic leukemia.